Literature DB >> 28590016

NHF and hypercapnia: How brief can you look?

Jens Bräunlich1, Hubert Wirtz1.   

Abstract

Entities:  

Keywords:  acute exacerbation of chronic obstructive pulmonary disease; hypercapnia; nasal high flow, respiratory insufficiency

Mesh：

Year:  2017        PMID： 28590016     DOI： 10.1111/resp.13092

Source DB:  PubMed          Journal:  Respirology        ISSN： 1323-7799            Impact factor:   6.424


× No keyword cloud information.
  4 in total

1.  Nasal high-flow versus noninvasive ventilation in patients with chronic hypercapnic COPD.

Authors:  Jens Bräunlich; Dominic Dellweg; Andreas Bastian; Stephan Budweiser; Winfried Randerath; Dora Triché; Martin Bachmann; Christian Kähler; Abdel Hakim Bayarassou; Irmhild Mäder; Jens Geiseler; Norbert Köhler; David Petroff; Hubert Wirtz
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-07-05

2.  High flow nasal therapy versus noninvasive ventilation as initial ventilatory strategy in COPD exacerbation: a multicenter non-inferiority randomized trial.

Authors:  Andrea Cortegiani; Federico Longhini; Fabiana Madotto; Paolo Groff; Raffaele Scala; Claudia Crimi; Annalisa Carlucci; Andrea Bruni; Eugenio Garofalo; Santi Maurizio Raineri; Roberto Tonelli; Vittoria Comellini; Enrico Lupia; Luigi Vetrugno; Enrico Clini; Antonino Giarratano; Stefano Nava; Paolo Navalesi; Cesare Gregoretti
Journal:  Crit Care       Date:  2020-12-14       Impact factor: 9.097

3.  Effects of nasal high flow on nocturnal hypercapnia, sleep, and sympathovagal balance in patients with neuromuscular disorders.

Authors:  Anna Christina Meyer; Jens Spiesshoefer; Nina Christina Siebers; Anna Heidbreder; Christian Thiedemann; Hartmut Schneider; Andrew T Braun; Winfried Randerath; Peter Young; Michael Dreher; Matthias Boentert
Journal:  Sleep Breath       Date:  2020-12-02       Impact factor: 2.816

4.  High-flow nasal cannula versus conventional oxygen therapy in acute COPD exacerbation with mild hypercapnia: a multicenter randomized controlled trial.

Authors:  Jingen Xia; Sichao Gu; Wei Lei; Jihua Zhang; Hui Wei; Chao Liu; Han Zhang; Rongli Lu; Liqiong Zhang; Mingyan Jiang; Chao Hu; Zhenshun Cheng; Chaojie Wei; Yusheng Chen; Fengfeng Lu; Min Chen; Hong Bi; Hui Liu; Cunzi Yan; Hong Teng; Yang Yang; Chen Liang; Yanlei Ge; Pengguo Hou; Jialin Liu; Weiwei Gao; Yi Zhang; Yingying Feng; Cheng Tao; Xu Huang; Pinhua Pan; Hong Luo; Chunmei Yun; Qingyuan Zhan
Journal:  Crit Care       Date:  2022-04-15       Impact factor: 19.334
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.